Related Experiment Video

Updated: Nov 30, 2025

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
06:29

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells

Published on: July 30, 2020

3.3K

Promising Therapy in Lung Cancer: Spotlight on Aurora Kinases

Domenico Galetta1, Lourdes Cortes-Dericks2

  • 1Division of Thoracic Surgery, European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Cancers
|November 18, 2020
PubMed

Insights

Targeting Aurora kinases, crucial for cell division, offers a promising new avenue for lung cancer treatment. Inhibiting these kinases may improve the effectiveness of existing therapies and enhance patient survival rates.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Lung cancer treatment remains challenging with poor prognosis.
  • Cell cycle regulation, particularly mitosis, is a key target in cancer management.
  • Aurora kinases (AURKA, AURKB) are implicated in lung cancer progression and survival.

Purpose of the Study:

  • To review the biology of Aurora kinases.
  • To highlight their oncogenic roles in lung cancer through pre-clinical and clinical studies.
  • To discuss the potential and challenges of Aurora kinase inhibitors in lung cancer therapy.

Main Methods:

  • Literature review of pre-clinical and clinical studies on Aurora kinases in lung cancer.
  • Analysis of the role of Aurora kinases in cell cycle regulation and mitosis.
  • Evaluation of Aurora kinase inhibitors as targeted therapies.

Main Results:

  • Aurora kinases are overexpressed in lung cancer and correlate with poor survival.
  • Inhibition of Aurora kinases can enhance the efficacy of chemotherapy and radiotherapy.
  • Aurora kinase inhibitors show significant potential for targeted lung cancer therapy.

Conclusions:

  • Aurora kinases represent a viable therapeutic target for lung cancer.
  • Targeted inhibition of Aurora kinases holds promise for improving treatment outcomes.
  • Further research is needed to overcome challenges and fully realize the potential of these inhibitors.
Keywords:
AURKAAURKBAurora kinaseslung cancerlung cancer therapy

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.3K